• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge

Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge

by Pallavi Upadhyay, PhD, CMPP | Mar 14, 2025 | Clinical Diagnostics Insider, Inside the Diagnostics Industry-dtet

The pandemic may have set the stage for a jump in infections from these four nemeses

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

Labcorp, Quest, and ARUP Develop Bird Flu Tests with CDC Help

by Ron Shinkman | Jan 28, 2025 | Clinical Diagnostics Insider, Testing Trends-dtet

The assays were developed with the CDC as part of recent trend of public-private partnerships to improve pandemic preparedness

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Watch: FDA Approves Enhanced Cologuard Cancer Test

FDA Watch: FDA Approves Enhanced Cologuard Cancer Test

by Ron Shinkman | Nov 1, 2024 | CDC-nir, Essential, FDA-lca, Lab Industry Advisor

Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
CDC Releases Recommendations to Address Rising Syphilis Cases

CDC Releases Recommendations to Address Rising Syphilis Cases

by Liv Gaskill, MSc | Mar 21, 2024 | Clinical Diagnostics Insider, Testing Trends-dtet

Key updates from the CDC’s new lab recommendations for syphilis testing.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
CDC Calls Continued Rise in Cases of STIs “Alarming”

CDC Calls Continued Rise in Cases of STIs “Alarming”

by Miriam Bergeret, MSc | May 5, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet

Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com